Evidence map›Paper›PMID 34943590›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Rita Elias, José Melo-Cristino, Luís Lito, Margarida Pinto, Luísa Gonçalves, Susana Campino, Taane G Clark, Aida Duarte, João Perdigão

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Detection of plasmid-mediatedInfectious diseases & immunity · 2025
    Article
  3. Ceftazidime-avibactam treatment dilemma of blaAnnals of clinical microbiology and antimicrobials · 2024
    Article
  4. ISmBio · 2024
    Article
  5. Article
  6. Marine Algae Extract (Bioinorganic chemistry and applications · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Rita EliasResearch Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0001-6959-9005
José Melo-CristinoLaboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Norte, 1649-049 Lisboa, Portugal.
Luís LitoLaboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Norte, 1649-049 Lisboa, Portugal.
Margarida PintoLaboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Central, 1169-050 Lisboa, Portugal.
Luísa GonçalvesServiço de Patologia Clínica, Hospital SAMS, 1849-019 Lisboa, Portugal.
Susana CampinoLondon School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Taane G ClarkLondon School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0001-8985-9265
Aida DuarteFaculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0002-0616-4650
João PerdigãoResearch Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
University of Lisbon · PTUniversity of London · GBCentro Hospitalar Lisboa Norte · PTUnidade Local de Saúde de São José · PT

Funding

Medical Research Council MR/K000551/1Medical Research Council MR/M01360X/1Medical Research Council MR/N010469/1Medical Research Council MR/R020973/1Medical Research Council MR/R025576/1Medical Research Council MR/S01988X/1Medical Research Council MR/S03563X/1
6 · The paper itself

Abstract

The emergence of multidrug resistant Gram-negative pathogens, particularly carbapenemase producers, has forced clinicians to use last line antibiotics, such as colistin. Since colistin susceptibility testing presents several challenges, this study aimed at evaluating the performance of two alternative susceptibility methods for

Indexed as

colistinKlebsiella pneumoniaeskipped wellssusceptibility testing

Identifiers

PMID34943590
PMCPMC8700027
OpenAlexW4200323435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.